Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket No. 97N-0068)

Journal Article

We believe the proposed model is appropriate to our current state of knowledge and recognize that FDA regulations will evolve as the field evolves. We thank you for the opportunity to work with FDA as its regulatory strategy is developed in the near future.

Duke Authors

Cited Authors

  • Shpall, EJ; Champlin, RE; Eaves, AC; Gee, AP; Collins, N; LeMaistre, CF; O'Reilly, R; Rowley, SD; Sullivan, K; Vaughan, WP; Warkentin, PL

Published Date

  • 1997

Published In

Volume / Issue

  • 6 / 4

Start / End Page

  • 287 - 289

PubMed ID

  • 9377066

International Standard Serial Number (ISSN)

  • 1061-6128